- Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia2021 | Second Faculty of Medicine
- The long non-coding RNA landscape in juvenile myelomonocytic leukemia2018 | Second Faculty of Medicine
- RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia2014 | Second Faculty of Medicine
- CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out2021 | Second Faculty of Medicine
- Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial2021 | Second Faculty of Medicine
- Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations2008 | Second Faculty of Medicine
- Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia2024 | Second Faculty of Medicine
- Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 12010 | Second Faculty of Medicine
- Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia2005 | Second Faculty of Medicine
- JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia2007 | Second Faculty of Medicine
- Mutations in CBL occur frequently in juvenile myelomonocytic leukemia2009 | Second Faculty of Medicine
- Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia2007 | Second Faculty of Medicine
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia2015 | Second Faculty of Medicine
- LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia2016 | Second Faculty of Medicine
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia2010 | Second Faculty of Medicine
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome2011 | Second Faculty of Medicine
- Differentiating juvenile myelomonocytic leukemia from infectious disease - Response1998 | Second Faculty of Medicine
- Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia2007 | Second Faculty of Medicine
- The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease2005 | Second Faculty of Medicine
- RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia2017 | Second Faculty of Medicine
- Bone marrow transplantation for juvenile myelomonocytic leukemia - waiting for successPublication without faculty affiliation
- Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia2008 | Second Faculty of Medicine
- The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)2004 | Second Faculty of Medicine
- Gene Expression-Based Classification As an Independent Predictor of Clinical Outcome in Juvenile Myelomonocytic Leukemia2010 | Second Faculty of Medicine
- Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML2012 | Second Faculty of Medicine
- Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 71999 | Second Faculty of Medicine
- Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial2005 | Second Faculty of Medicine
- HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia2009 | Second Faculty of Medicine
- Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft2023 | Second Faculty of Medicine
- Cytogenetic evaluation of children with MDS and juvenile myelomonocytic leukemia (JMML) - results of the european working group of childhood MDS (EWOG-MDS)Publication without faculty affiliation